Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma

NCT00568308 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

600

Enrollment

INDUSTRY

Sponsor class

Stopped Commercial decision to discontinue the study

Conditions

Cancer
Liver Cancer
Primary Liver Cancer
Hepatocellular Carcinoma
Hepatoma

Interventions

DRUG: PI-88
DRUG: placebo

Sponsor

Progen Pharmaceuticals